Activity value 76india Buyer&Supplier,Last transaction date:
2026-02-17Address: 707,autumn grove, lokhandwalacomplex, kandivali [e,mumbai,400101
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for bruck pharma pvt ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 29 transactions, with a transaction quantity of 10421.6 and a transaction weight of 3.6.
Suppliers
bruck pharma pvt ltd.
Buyers
hb human bioscience s.a.s.
POLs
——
PODs
bogota
Supply area
India
Purchas area
Colombia
Weight
1.33kg
Amount
20979
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 2615522 PEDIDO TRAMITE: ERWINIA - LOTE L24F051B DECLARACION(1-1) MERCANCIA UBICADA EN ZONA FRANCA BOGOTA CRA 106 N. 15A -25 INT 141 OFICINA 501 PHARMAQUILA SAS //. FACTURA: BP/D/022/24-25 FECHA: 2024-07-12 PRODUCTO: ASPARAGINASA ERWINIA (10000 UI) POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE (HB DADANTII), NOMBRE COMERCIAL: ASPARAGINASA ERWINIA (CRISANTASPASA), PRINCIPIO ACTIVO: ASPARAGINASA ERWINIA, CONCENTRACION: 10000 UI, INDICACIONES TERAPEUTICAS: ONCOLOGICO, FORMA FARMACEUTICA: POLVOLIOFILIZADO, TIPO DE EMPAQUE: CAJAS X UN (1) VIAL., USO: COMPONENTE DE UN REGIMEN QUIMIOTERAPEUTICO DE MULTIPLES AGENTES PARA EL TRATAMIENTO DE PACIENTES CON LEUCEMIA LINFOBLASTICA AGUDA (LLA) QUE HAN DESARROLLADO HIPERSENSIBILIDAD A LA ASPARAGINASA DERIVADA DE E. COLI., MARCA: HB DADANTII, PAIS ORIGEN: INDIA - 361. CANTIDAD (74) U, LOTE: L24F051B - VTO LOT: MAY-26 (ITEM 1).
Expand
bruck pharma pvt ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as injection,pharmaceutical product,bat.
According to the 52wmb.com global trade database, as of 2026-02-17, the company has completed 1606 international trades,
with its main trading regions covering philippines,cambodia,bosnia - herzegovina etc.
The core products include HS30049049,HS30049099,HS30049089000 etc,
often transported via mumbai (ex bombay),port sahar air cargo acc inbom4, port bombay air etc,
and its main trading partners are nelpa lifesciences inc.,rra&be logistica de mexico s.a.de c.v.,hiwa cancer hospital.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on bruck pharma pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.